947248-52-4

Basic information

• Product Name: 6-BROMO-IMIDAZO[1,2-A]PYRIDIN-2-AMINE
• Synonyms: IMIDAZO[1,2-A]PYRIDIN-2-AMINE, 6-BROMO-;2-Amino-6-bromoimidazo[1,2-a]pyridine;(6-BroMoiMidazo[1,2-a]pyridin-2-yl)aMine;6-broMoH-iMidazo[1,2-a]pyridin-2-aMine
• CAS NO: 947248-52-4
• Molecular Formula: C₇H₆BrN₃
• Molecular Weight: 212.05
• Mol File: 947248-52-4.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• Density: 1.87g/cm³
• Refractive Index: 1.753
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• PKA: 8.45±0.50(Predicted)
• CAS DataBase Reference: 6-BROMO-IMIDAZO[1,2-A]PYRIDIN-2-AMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 6-BROMO-IMIDAZO[1,2-A]PYRIDIN-2-AMINE(947248-52-4)
• EPA Substance Registry System: 6-BROMO-IMIDAZO[1,2-A]PYRIDIN-2-AMINE(947248-52-4)

Safety Data

• Hazardous Substances Data: 947248-52-4(Hazardous Substances Data)

Usage

General Description

6-BROMO-IMIDAZO[1,2-A]PYRIDIN-2-AMINE is a chemical compound with the molecular formula C7H6BrN5. It is a brominated imidazopyridine derivative, which has potential applications in pharmaceutical and chemical research. 6-BROMO-IMIDAZO[1,2-A]PYRIDIN-2-AMINE is an important intermediate in the synthesis of various pharmaceutical compounds and agrochemicals. It may also be used as a building block for the preparation of various heterocyclic compounds with potential biological activities. Additionally, it has been studied for its potential anticancer and antiviral properties, making it a valuable compound for further research and development in the field of medicinal chemistry.

InChI:InChI=1/C7H6BrN3/c8-5-1-2-7-10-6(9)4-11(7)3-5/h1-4H,9H2

Upstream product

• 207801-52-3 N-(5-bromopyridin-2-yl)-4-methylbenzenesulfonamide 
• 1072-97-5 5-bromo-2-pyridylamine 
• 937014-94-3 (Z)-2-(5-bromo-2-(tosylimino)pyridin-1(2H)-yl)acetamide 
• 504413-35-8 N-(6-bromoimidazo[1,2-a]pyridin-2-yl)-2,2,2-trifluoroacetamide 

Downstream Products

• 947249-08-3 N-(6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine-2-yl)acetamide 
• 1162680-84-3 N-(6-bromoimidazo[1,2-a]pyridin-2-yl)acetamide 
• 1005775-52-9 4-tert-butyl-N-(6-bromoimidazo[1,2-a]pyridin-2-yl)benzamide 
• 1005775-61-0 4-tert-butyl-N-[6-(pyridin-3-yl)imidazo[1,2-a]pyridin-2-yl]benzamide 
• 1005775-72-3 4-tert-butyl-N-[6-phenylimidazo[1,2-a]pyridin-2-yl]benzamide 
• 1162680-37-6 N-(5-(2-aminoimidazo[1,2-a]pyridin-6-yl)-2-chloropyridin-3-yl)-4-fluorobenzenesulfonamide 
• 947248-55-7 (6-bromo-imidazo[1,2-a]pyridin-2-yl)-carbamic acid phenyl ester 

Relevant articles and documents

HETEROARYL COMPOUNDS AS NECROSIS INHIBITORS, COMPOSITION AND METHOD USING THE SAME

The present disclosure provides heteroaryl compounds of Formula (I), processes for their preparation, pharmaceutical compositions containing them, and their use in the treatment of diseases and disorders, arising from or related to necrosis. Formula (I) i

FUSED BICYCLIC COMPOUNDS AS INHIBITORS FOR PI3 KINASE

The invention relates to compounds of formula (I) for the regulation of phosphoinositides 3-kinases activity and related diseases.

BICYCLIC HETEROARYL COMPOUNDS AND THEIR USE AS KINASE INHIBITORS

Phosphatidylinositol (PI) 3-kinase inhibitor compounds, their pharmaceutically acceptable salts, and prodrugs thereof; compositions of the new compounds, either alone or in combination with at least one additional therapeutic agent, with a pharmaceutically acceptable carrier; and uses of the new compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of proliferative diseases characterized by the abnormal activity of growth factors, protein serine/threonine kinases, and phospholipid kinases.